Home Newsfeeds Cowen & Co. Maintains Outperform on Allegro Microsystems, Raises Price Target to $44

Cowen & Co. Maintains Outperform on Allegro Microsystems, Raises Price Target to $44

Cowen & Co. analyst Joshua Buchalter maintains Allegro Microsystems (NASDAQ:ALGM) with a Outperform and raises the price target from $38 to $44.

byBenzinga Newsdesk

February 1, 2023

1 minute read

Cowen & Co. analyst Joshua Buchalter maintains Allegro Microsystems (NASDAQ:ALGM) with a Outperform and raises the price target from $38 to $44.

Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $43

By Benzinga Newsdesk

November 21, 8:24 AM

Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and lowers the price target from $45 to $43.

TWST

Benzinga Bulls And Bears: Tesla, Microsoft, Apple, Novavax And Why Dogecoin May Be Poised For 50% Surge

By Michael Cohen

March 4, 4:01 PM

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

$DOGE

News

Arnold Schwarzenegger Tries To Fix LA Pothole Problem — But Ends Up Filling A Service Trench Instead

By Anan Ashraf

April 13, 3:34 AM

Actor and former California Governor Arnold Schwarzenegger tried to fix a pothole problem in his neighborhood in Los…

SRE

Cannabis Rescheduling Signals Strong Returns, Tax Breaks Could Increase This Stock’s Market Cap By 170%

By Nicolas Jose Rodriguez

May 22, 12:50 PM

According to a recent report by Pablo Zuanic of Zuanic & Associates, MariMed (OTC: MRMD) a multi-state cannabis operator (MSO) is positioned for significant stock gains.

MRMD

Cowen & Co. Maintains Outperform on Allegro Microsystems, Raises Price Target to $44

Related Posts

Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $43

Benzinga Bulls And Bears: Tesla, Microsoft, Apple, Novavax And Why Dogecoin May Be Poised For 50% Surge

Arnold Schwarzenegger Tries To Fix LA Pothole Problem — But Ends Up Filling A Service Trench Instead

Cannabis Rescheduling Signals Strong Returns, Tax Breaks Could Increase This Stock’s Market Cap By 170%